Allegations of falsification or misrepresentation of scientific data are not unknown in the healthcare industry, however, what has become public knowledge still can be characterised as “occasional”. Only a few days ago, Sanofi-Aventis was able to breathe a temporary sigh of relief as a ...
Please Login to read the full article.
